Table of Contents
Electronic Health Record Companies Market Overview
Electronic Health Record companies (EHRs) provide digital systems that store and manage comprehensive patient health information, including demographics, medical history, medication details, and test results.
They enhance the quality and safety of care by providing real-time, accessible records to authorized healthcare providers.
Key advantages include improved access to patient data, reduced manual errors, increased efficiency, and integrated data across healthcare systems.
However, challenges such as data security, interoperability, and cost persist. EHRs must comply with regulations like HIPAA and the Meaningful Use program.
Future trends include AI integration, expanded patient portals, and exploration of blockchain technology to improve security and interoperability.
Market Drivers
The global Electronic Health Record (EHR) market is primarily driven by the need for efficient healthcare delivery, government incentives, and a focus on improving patient safety and care quality.
Technological advancements, such as cloud computing and AI, facilitate the development of advanced EHR systems.
Additionally, the rising population, aging demographics, and increasing healthcare costs drive demand for scalable and cost-effective solutions.
The push for better data integration and patient engagement further supports the growth of the EHR market.
Market Size
The global Electronic Health Records market is projected to reach approximately USD 45.9 billion by 2033. Up from USD 27.1 billion in 2023, with a CAGR of 5.4% from 2024 to 2033.
List of Major Companies
These are the top 10 companies operating in the Electronic Health Record Market:
Epic
Company Overview
| Establishment Year | 1979 |
| Headquarter | Verona, Wisconsin, United States |
| Key Management | Judith Faulkner (CEO) |
| Revenue (US$ Bn) | $ 4.6 Billion (2022) |
| Headcount | ~ 13,000 (2023) |
| Website | https://www.epic.com/ |
About Epic Systems
Epic Systems Corporation, a leading EHR provider, is enhancing its offerings through advanced technologies.
Like generative AI and GPT-4, in partnership with Microsoft, to boost clinical efficiency and personalize patient care.
The company is engaged in over 60 AI projects to improve operations and actively participates in national interoperability efforts.
Such as TEFCA, to enable seamless health information sharing. Additionally, Epic is involved in major health IT projects, including Quebec’s new digital health system.
Demonstrating its commitment to leveraging technology for better healthcare outcomes and streamlined processes.
Geographical Presence
Epic Systems Corporation, headquartered in Verona, Wisconsin, is a leading provider of electronic health record (EHR) solutions with a prominent presence in the US.
Serving major health systems and hospitals across the Northeast, Midwest, South, and West. Its solutions are implemented in institutions like North-western Medicine and the Texas Medical Center.
Internationally, Epic’s footprint includes Canada, the United Kingdom, Australia, the United Arab Emirates, and Saudi Arabia, with selective expansions in Europe and Asia.
The company typically enters new markets through partnerships and adaptations to local healthcare needs.
Recent Developments
- In May 2023, Epic and Microsoft partnered to introduce generative AI technology into electronic health records for the first time.
- In March 2023, Epic Systems Corporation partnered with Northwell Health to implement its next-generation electronic health record.
IQVIA
Company Overview
| Establishment Year | 1982 |
| Headquarter | Durham, North Carolina, U.S. |
| Key Management | Ari Bousbib (Chairman & CEO) |
| Revenue (US$ Bn) | $ 15.4 B (2023) |
| Headcount | ~ 86,000 (2023) |
| Website | http://iqvia.com/ |
About IQVIA
IQVIA, a prominent player in the electronic health record companies/sector, has been actively enhancing its technological capabilities and market presence through various strategic initiatives.
In recent developments, IQVIA has expanded its partnership with Salesforce to accelerate digital innovation in healthcare, enabling smarter decisions and improved health outcomes.
The company is also integrating advanced AI and machine learning technologies to create robust, healthcare-grade AI solutions.
Additionally, IQVIA has introduced new patient experience solutions, leveraging Apple devices to offer personalized digital patient support programs, which significantly enhance patient engagement and outcomes.
These initiatives are complemented by the company’s ongoing efforts to innovate with AI-driven tools and real-time data analytics, underscoring IQVIA’s commitment to transforming healthcare delivery and patient care through technology.
Geographical Presence
IQVIA, a global leader in advanced analytics and contract research services for the healthcare industry, maintains a widespread geographical presence.
In North America, the company is headquartered in Durham, North Carolina, with extensive operations across the US and Canada.
In Europe, IQVIA operates in major markets, including the UK, Germany, France, Spain, Italy, and Switzerland, providing clinical, data, and consulting services.
In the Asia-Pacific region, the company has significant operations in China, India, and Japan. Latin American presence includes Brazil and Mexico, while in the Middle East and Africa, IQVIA is active in South Africa and the UAE.
This broad geographic footprint supports IQVIA’s mission to advance healthcare through innovative solutions and comprehensive market insights.
Recent Developments
- In May 2024, IQVIA’s subsidiary, Q2 Holdings Inc., announced the launch of Q2 Engage.
- In April 2024, IQVIA partnered with Salesforce globally to enhance the development of Salesforce’s Life Sciences Cloud.
Cerner
Company Overview
| Establishment Year | 1979 |
| Headquarter | Kansas City, Missouri, US |
| Key Management | David Feinberg (CEO) |
| Revenue (US$ Bn) | $ 5.8 Billion (2021) |
| Headcount | ~ 25,150 (2021) |
| Website | http://cerner.com/ |
About Oracle Cerner
Oracle Cerner, formerly Cerner Corporation, is a major player in the electronic health record companies following its $28.3 billion acquisition by Oracle in June 2022.
This acquisition integrates Cerner’s EHR solutions with Oracle’s cloud infrastructure, aiming to advance healthcare through new technologies.
Recent innovations include generative AI and voice-enabled features in their EHR platforms, which aim to ease administrative tasks and improve patient interactions.
The company is also working on a national EHR database to improve data interoperability. Despite facing competition from rivals like Epic Systems in the US, Oracle Cerner’s innovations, such as the Oracle Clinical Digital Assistant, are expected to enhance clinical workflows and patient care.
Geographical Presence
Oracle Cerner, a leading provider of healthcare IT solutions, operates globally and has a significant presence in key regions. In North America, the company is prominent in the US and Canada, with extensive facilities and services.
In Europe, it serves countries like the UK, Germany, France, and others, focusing on integrating EHR systems.
The Asia-Pacific region includes Australia, India, China, and other countries where Cerner supports local healthcare systems.
In Latin America, its operations span Brazil, Mexico, and other nations. At the same time, in the Middle East and Africa, Cerner is active in the UAE, South Africa, and beyond, providing tailored healthcare IT solutions worldwide.
Recent Development
- In February 2023, Oracle Cerner entered a 10-year agreement with Nova Scotia to implement an integrated electronic care record system for over one million residents.
- In February 2023, Oracle Cerner partnered with King’s College Hospital London to drive and expedite innovation.
GE-Healthcare
Company Overview
| Establishment Year | 1994 |
| Headquarter | Chicago, Illinois, United States |
| Key Management | Peter Arduini (CEO) |
| Revenue (US$ Bn) | $ 19.6 Billion (2023) |
| Headcount | ~ 51,000 (2023) |
| Website | http://gehealthcare.com/ |
About GE Healthcare
GE Healthcare, a leading force in electronic health record companies (EHR), is advancing its digital health capabilities through innovations and strategic acquisitions.
Notably, the introduction of the Edison Digital Health Platform integrates clinical data using AI and advanced analytics to enhance patient care and operational efficiency.
The acquisition of MedPlexus strengthens its support for independent physician practices with a SaaS model.
Recent efforts include partnerships with Leidos for smooth platform integration and expanding mobile access to medical records.
These initiatives highlight GE Healthcare’s dedication to advancing IT solutions that boost clinical and financial outcomes in healthcare settings.
Geographical Presence
GE Healthcare, a division of General Electric, operates globally and has a significant presence across various regions.
In North America, its headquarters are in Chicago, with additional facilities in major U.S. cities and Canada. In Europe, the company has key operations in the UK, Germany, and France, among other countries.
In the Asia-Pacific region, GE Healthcare was established in China, India, Japan, and Australia. In Latin America, its footprint includes Brazil and Mexico. While in the Middle East and Africa, it operates in the UAE, South Africa, and other African countries.
This broad geographical presence supports its role as a leading provider of medical technologies and services worldwide.
Recent Development
- In July 2024, GE Healthcare agreed to acquire Intelligent Ultrasound Group PLC’s clinical AI software business for $51 million.
- In March 2022, GE Healthcare revealed plans to launch the Edison Digital Health Platform, a vendor-neutral solution for data aggregation and AI integration.
McKesson
Company Overview
| Establishment Year | 1833 |
| Headquarter | Irving, Texas, US. |
| Key Management | Brian S. Tyler (CEO) |
| Revenue (US$ Bn) | $ 308.9 B (2024) |
| Headcount | ~ 51,000 (2024) |
| Website | http://mckesson.com/ |
About McKesson
McKesson Corporation, a significant player in electronic health record companies (EHR), is advancing its health IT solutions with innovations such as the oncology-specific iKnowMed system.
This system, recognized as a Qualified Clinical Data Registry (QCDR), helps oncology practices streamline data submission and reduce administrative tasks.
Recent developments include a partnership with the US Food and Drug Administration to use real-world data to understand rare cancers and acquisitions like the Cancer Center of Kansas to bolster community oncology.
Additionally, McKesson is applying predictive analytics to assist health systems in making better formulary and purchasing decisions, enhancing patient outcomes and operational efficiency.
These efforts underscore McKesson’s dedication to leveraging technology and data to advance healthcare.
Geographical Presence
McKesson Corporation, a major player in healthcare distribution, has a significant global presence. In North America, its core market includes extensive operations in the US and Canada, serving pharmacies, hospitals, and healthcare providers.
In Europe, McKesson operates through subsidiaries such as Celesio AG in Germany and McKesson UK, with additional activities in France, Italy, Spain, and Switzerland.
The company is also active in the Asia-Pacific region, particularly in Australia, and has a growing presence in Latin America, including Brazil.
While its footprint in the Middle East and Africa is more limited, McKesson continues to expand its global reach through strategic partnerships and distribution networks.
Recent Developments
- In June 2024, Accord BioPharma chose Biologics by McKesson to supply the CAMCEVI (leuprolide) 42mg injection emulsion.
- In April 2024, Reata Pharmaceuticals appointed Biologics by McKesson as the exclusive specialty pharmacy provider for SKYCLARYSTM (omaveloxolone).
Athenahealth
Company Overview
| Establishment Year | 1997 |
| Headquarter | Boston, Massachusetts, US. |
| Key Management | Bob Segert (Chairman & CEO) |
| Revenue (US$ Bn) | $ 1.6 Billion (2023) |
| Headcount | ~ 7,717 (2024) |
| Website | http://athenahealth.com/ |
About Athenahealth
In 2024, Athenahealth, Inc. enhanced its electronic health record companies offering by introducing a new suite of specialty solutions for women’s health and urgent care aimed at streamlining practice management.
The company was honored with the 2024 KLAS Points of Light Award for its efforts in modernizing the prior authorization process, underscoring its focus on reducing administrative burdens and improving patient access.
Athenahealth also launched new interoperability features for seamless data exchange and actionable insights.
Its collaborations with major providers, such as New York-Presbyterian, highlight its capability to support large-scale healthcare improvements.
Geographical Presence
Athenahealth, Inc. primarily operates in North America, with a significant presence in the United States, where its cloud-based healthcare solutions are widely used across various healthcare settings.
The company has also expanded into the United Kingdom, targeting advanced healthcare markets outside the US.
While its international footprint is currently limited, Athenahealth’s strategic focus on these regions reflects its broader goals of global market penetration and growth in the healthcare IT sector.
Recent Developments
- In June 2024, Athenahealth, Inc. partnered with Cardiovascular Associates of America (CVAUSA) to enhance cardiology care delivery and patient experience through innovative solutions.
- In May 2024, Athenahealth introduced athenaOne for Women’s Health and athenaOne for Urgent Care to provide specialized solutions for specific medical practices and care settings.
NextGen
Company Overview
| Establishment Year | 1973 |
| Headquarter | Atlanta, Georgia, U.S. |
| Key Management | David Sides (CEO) |
| Revenue (US$ Bn) | $ 653.2 Million (2023) |
| Headcount | ~ 2,783 (2023) |
| Website | https://nextgen.com/ |
About NextGen Healthcare
NextGen Healthcare, Inc. continues to strengthen its position in the electronic health record companies (EHR) sector with innovative solutions and strategic collaborations.
In recent developments, NextGen expanded its collaboration with the American Podiatric Medical Association to enhance its cloud-based EHR platform, NextGen Office, by incorporating specialized blueprints for podiatry practices.
This initiative aims to address issues like diabetes and infection management effectively. Additionally, the company was named a leader in the IDC MarketScape U.S.
Electronic Health Record 2023-2024 Vendor Assessment, highlighting its advanced functionalities, such as voice recognition and secure ambient listening.
Which enhances user experience and regulatory compliance. These advancements reflect NextGen’s commitment to improving healthcare outcomes through technology and customer-focused solutions.
Geographical Presence
NextGen Healthcare, Inc. operates extensively across North America, with a significant presence in the United States and Canada, and has established a foothold in the United Kingdom and Australia within Europe and Asia-Pacific, respectively.
The company is also exploring opportunities in other European countries, as well as expanding into Brazil and other parts of Latin America.
This strategic geographical presence allows NextGen Healthcare to provide its integrated healthcare solutions to a diverse range of providers, adapting to varying regional healthcare systems and regulatory environments.
Recent Developments
- In March 2024, NextGen Healthcare was chosen by United Medical Centers to improve integration across its specialties and care sites as it expands its services.
- In February 2024, NextGen Healthcare partnered with SCHIO to help Californian suppliers comply with the state’s new data exchange regulations.
Veradigm
Company Overview
| Establishment Year | 1982 |
| Headquarter | Chicago, Illinois, US. |
| Key Management | Rick Poulton (CEO) |
| Revenue (US$ Bn) | $ 1.5 Billion (2020) |
| Headcount | ~ 8,000 (2020) |
| Website | http://veradigm.com/ |
About Veradigm
Veradigm Inc., a prominent player in the electronic health record companies (EHR) sector, continues to innovate and expand its product offerings to improve healthcare delivery.
In 2024, the company highlighted its new EHR-integrated Care Gap Alert solution designed to enhance patient care by identifying and addressing care gaps in real-time.
Veradigm also launched the Allscripts Patient Kiosk, which integrates Fujitsu PalmSecure technology for secure and efficient patient check-ins, reducing paperwork and improving data accuracy.
Additionally, Veradigm announced a strategic collaboration with Coordinated Health to implement its comprehensive EHR and practice management solutions, further streamlining patient care across multiple settings.
These developments reflect Veradigm’s ongoing commitment to leveraging advanced technology to improve clinical workflows and patient outcomes.
Geographical Presence
Veradigm Inc. operates extensively across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
In the United States and Canada, the company provides a broad range of healthcare IT solutions, including EHRs and data analytics.
In Europe, it caters to markets like the UK and Germany, while in the Asia-Pacific region, it serves Australia and India. However, Veradigm is expanding into Brazil and South Africa, as well as Latin America and Africa.
Moreover, The company’s global presence is supported by strategic partnerships and collaborations, enabling it to deliver tailored solutions and meet diverse regional needs effectively.
Recent Development
- In April 2024, Veradigm partnered with Vim to improve point-of-care integration for EHR platforms and payers beyond its own EHR network.
- In January 2024, Veradigm announced a collaboration with MedAllies to expand patient data access for providers using its EHR systems.
Greenway
Company Overview
| Establishment Year | 1998 |
| Headquarter | Tampa, Florida, US. |
| Key Management | Pratap Sarker (CEO) |
| Revenue (US$ Bn) | $ 427 Million (2023) |
| Headcount | ~ 1,293 (2023) |
| Website | http://www.greenwayhealth.com/ |
About Greenway
In 2024, Greenway Health, a leader in electronic health record companies (EHR), introduced major updates to its EHR platforms.
Intergy and Prime Suite, enhancing user experience, clinical workflows, and patient outcomes. The updates feature streamlined interfaces, simplified navigation, and improved integration with cutting-edge innovations.
Moreover, Greenway Health also launched Greenway Insights™, a cloud-based platform offering advanced analytics and machine learning.
However, Compliant with the 21st Century Cures Act and utilizes FHIR APIs for better data interoperability.
The company remains active in industry events like the reENGAGE summit, focusing on collaborative learning and technological advancements.
Recent leadership changes and industry awards further highlight Greenway Health’s commitment to advancing healthcare technology.
Geographical Presence
Greenway Health, headquartered in Tampa, Florida, has a robust geographical presence primarily in North America, with regional offices in major U.S. cities and a client base extending across the country.
The company also serves Canadian healthcare providers and is expanding its footprint in Europe, with notable operations in the UK and Germany.
In the Asia-Pacific region, Greenway Health has a growing presence in Australia and is establishing its market in India.
Additionally, the company is working to penetrate markets in the Middle East and Africa, with a focus on the UAE and South Africa, and is exploring opportunities in Latin America, including Brazil and Mexico.
Recent Developments
- In December 2021, Greenway Health announced new data capabilities with Greenway Insights™ for its clients.
- In August 2021, Greenway Health doubled its investment in Intergy and Prime Suite to serve client and industry needs better.
PerkinElmer
Company Overview
| Establishment Year | 1937 |
| Headquarter | Waltham, Massachusetts, US. |
| Key Management | Dirk Bontridder (CEO) |
| Revenue (US$ Bn) | $ 2.8 Billion (2022) |
| Headcount | ~ 11,500 (2022) |
| Website | https://www.perkinelmer.com/analytical-and-enterprise-solutions.html |
About PerkinElmer
PerkinElmer, a global leader in life sciences and diagnostics, has recently refocused its operations. By divesting its Applied, Food, and Enterprise Services businesses to New Mountain Capital for $2.45 billion in March 2023.
This strategic shift enables the company to concentrate on its high-growth life sciences and diagnostics sectors, now under the rebranded entity Revvity, Inc., which is dedicated to advancing disease diagnosis and personalized therapies.
Recent initiatives include acquiring Covaris to enhance genomic and proteomic research capabilities and integrating advanced informatics and automation tools to improve workflow efficiency and data insights.
These steps highlight PerkinElmer’s commitment to driving healthcare innovation and enhancing patient outcomes.
Geographical Presence
PerkinElmer, Inc. operates globally and has a robust presence across multiple regions. In North America, it has significant facilities in the United States, including its headquarters in Massachusetts and regional offices in Canada.
In Europe, key locations include the United Kingdom, Germany, France, Italy, and Spain. The company is also well-established in Asia-Pacific, with major operations in China, India, Japan, Australia, and South Korea.
Moreover, In Latin America, it has a presence in Brazil and Mexico, while in the Middle East and Africa, its operations span South Africa and the United Arab Emirates.
Lastly, This extensive geographical footprint supports PerkinElmer’s global strategy and enhances its ability to serve diverse markets.
Recent Developments
- In April 2024, PerkinElmer and Early Check commenced the study of genome sequencing.
- In December 2023, PerkinElmer acquired Covaris to expand its life sciences portfolio.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
